COMMUNIQUÉS West-GlobeNewswire

HIV Self-Testing Just Got Faster: FDA Approves the 1-Minute INSTI® HIV Self Test
14/10/2025
The fastest, at-home HIV test is now available in the U.S., expanding access to rapid, private, and convenient self-testing A Major Step Forward in HIV Prevention The INSTI ® HIV Self Test delivers highly accurate [...]
Dewpoint Therapeutics Announces Presentation at AACR-NCI-EORTC 2025
14/10/2025
Dewpoint will present one poster at AACR-NCI-EORTC MYC is a highly desirable oncogenic target that historically eluded drug hunters Small molecules that inhibit the oncogenic function of MYC were discovered using [...]
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases
14/10/2025
Press Release EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases Through this funding round, the company will initiate the clinical development of its first therapeutic candidate, [...]
American teacher undergoes cardiac treatment in Xiamen
14/10/2025
XIAMEN, China , Oct. 14, 2025 (GLOBE NEWSWIRE) -- Kevin Klein, an American teacher from Xiamen International School, underwent coronary angiography and radio-frequency ablation on Sep 26 at the Xiamen Cardiovascular [...]
24/7 Market News - Kraig Labs Working to Make Spider Silk a Once-in-a-Generation Technological Breakthrough
14/10/2025
DENVER, Oct. 14, 2025 (GLOBE NEWSWIRE) -- All the buzz around technology today is centered on Artificial Intelligence, Robotics, Digital Currency ($BTC), and the rare earth minerals used to build them. However, these [...]
Validic to Showcase Dual Solutions at HLTH 2025: Wearable Data API for Digital Health and EHR-Integrated Remote Patient Monitoring for Health Systems
14/10/2025
Platform Serves Two Distinct Markets with Comprehensive Wearable Integration APIs and Epic-Integrated Remote Patient Monitoring with AI-powered Insights STERLING, Va., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Validic today [...]
Orion publishes Interim Report for January–September 2025 and holds a webcast on 28 October 2025
14/10/2025
ORION CORPORATION PRESS RELEASE 14 OCTOBER 2025 at 11.15 EEST Orion publishes Interim Report for January–September 2025 and holds a webcast on 28 October 2025 Orion will publish Interim Report for January–September 2025 [...]
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
14/10/2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ” or the “Company”) (Nasdaq/AIM:HCM, HKEX:13) today announces that Professor Tan Shao Weng, Daniel [...]
Abalos Therapeutics Publishes in Cell Reports Medicine Validating ABX-001’s Potential to Overcome Cancer Immunotherapy Hurdles
14/10/2025
-- Preclinical data support Abalos’ first-in-class approach of safely harnessing the immunostimulatory and anti-tumoral properties of arenaviruses to treat solid tumors -- Düsseldorf, Germany, October 14, 2025 – Abalos [...]
Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarity™ Monitoring Solution for Hospitals and Health Systems
14/10/2025
New capability aims to address the growing threat of workplace violence in healthcare settings, building on the company’s suite of AI-enabled solutions that leverage purpose-built technology to transform care NEW YORK, [...]
Soleo Health Introduces State-of-the-Art Pharmacy and Infusion Center in Washington, D.C., Area
14/10/2025
New Location Expands Service and Support to Patients Along Mid-Atlantic Corridor FRISCO, Texas and HERNDON, Va., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Soleo Health , a national provider of complex specialty pharmacy [...]
PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities
14/10/2025
New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than $300 at scale MENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most [...]
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
14/10/2025
Debt-free balance sheet with $13.3 million in cash as of today ($15.11 per share fully diluted) providing strategic flexibility for continued commercial growth Nociscan scan volumes increase +89% year-over-year with [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025
14/10/2025
Company Announcement Net sales of DARZALEX ® in the third quarter of 2025 totaled USD 3,672 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc [...]
Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity
14/10/2025
– Financing led by new investor Bain Capital Private Equity with participation from new and existing investors to support continued development of a differentiated, late-stage portfolio of obesity treatments – – [...]
BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes
14/10/2025
Completes clinical trials required by FDA for sNDA submission planned for the first quarter of 2026 NEW HAVEN, Conn., Oct. 14, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical [...]
Nusano and Ariceum Therapeutics Announce Multi-Isotope Supply Agreement
14/10/2025
Agreement includes Actinium-225 (Ac-225) and Lutetium-177 (Lu-177) to support Ariceum’s therapeutic programs WEST VALLEY CITY, Utah and BERLIN, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming [...]
Frontier Medicines Announces Third Precision Oncology Development Candidate
14/10/2025
- FMC-242 is a potentially best-in-class covalent allosteric inhibitor that breaks the interaction between PI3Kα and RAS, targeting the largest genetic drivers of cancer - - Potential as a monotherapy and as a [...]
Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant
14/10/2025
CAMBRIDGE, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading live biotherapeutics company, today announced that new post hoc data from its SER-155 Phase [...]

Pages